Featured

[Special Report] Trademark filing and litigation trends 2024: Insights and opportunities

Robert Reading

Director, Corporate Strategy, Content at Clarivate

Biopharma
What a string of semaglutide biosimilars could mean for Mainland China
Academia and Government
Introducing the Clarivate Academic AI Platform
Academia and Government
March 1, 2017
Academia and Government
March 1, 2017
Academia and Government
February 28, 2017
Life Sciences and Healthcare
February 28, 2017
Academia and Government
February 24, 2017
Academia and Government
February 24, 2017
Academia and Government
February 23, 2017
Academia and Government
February 22, 2017
Intellectual Property
February 20, 2017
Academia and Government
February 16, 2017
Life Sciences and Healthcare
February 16, 2017
Academia and Government
February 16, 2017